- Home
- BIAF vs FTEL Comparison
BIAF vs FTEL Comparison
Compare BIAF & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- FTEL
- Stock Information
- Founded
- BIAF 2014
- FTEL 2007
- Country
- BIAF United States
- FTEL Australia
- Employees
- BIAF N/A
- FTEL N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FTEL
- Sector
- BIAF Health Care
- FTEL
- Exchange
- BIAF Nasdaq
- FTEL Nasdaq
- Market Cap
- BIAF 12.2M
- FTEL 11.1M
- IPO Year
- BIAF 2022
- FTEL 2023
- Fundamental
- Price
- BIAF $0.30
- FTEL $0.51
- Analyst Decision
- BIAF Hold
- FTEL
- Analyst Count
- BIAF 1
- FTEL 0
- Target Price
- BIAF N/A
- FTEL N/A
- AVG Volume (30 Days)
- BIAF 11.2M
- FTEL 222.3K
- Earning Date
- BIAF 08-13-2025
- FTEL 07-07-2025
- Dividend Yield
- BIAF N/A
- FTEL N/A
- EPS Growth
- BIAF N/A
- FTEL N/A
- EPS
- BIAF N/A
- FTEL N/A
- Revenue
- BIAF $8,809,228.00
- FTEL $4,990,695.00
- Revenue This Year
- BIAF N/A
- FTEL N/A
- Revenue Next Year
- BIAF $20.00
- FTEL N/A
- P/E Ratio
- BIAF N/A
- FTEL N/A
- Revenue Growth
- BIAF 78.40
- FTEL 29.02
- 52 Week Low
- BIAF $0.16
- FTEL $0.36
- 52 Week High
- BIAF $2.99
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- BIAF 50.96
- FTEL 42.43
- Support Level
- BIAF $0.22
- FTEL $0.36
- Resistance Level
- BIAF $0.46
- FTEL $0.50
- Average True Range (ATR)
- BIAF 0.04
- FTEL 0.05
- MACD
- BIAF 0.01
- FTEL 0.00
- Stochastic Oscillator
- BIAF 30.51
- FTEL 49.08
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.